The biology of nitric oxide

Functional Neurology

Volumn 12, Issue 3-4, 1997, Pages 135-140

  Moncada, Salvador ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Immunology; Inflammation neurotransmission; Nitric oxide; Vascular endothelium

Indexed keywords

NITRIC OXIDE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; IMMUNOLOGY; INFLAMMATION; NEUROTRANSMISSION; PERIPHERAL NERVOUS SYSTEM; VASCULAR ENDOTHELIUM;

EID: 0030855432     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;238:373-376
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
3. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharm Revs 1991; 43:109-142
5. Moncada S, Higgs A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-1330
6. Huang PL, Huang Z, Mashimo H et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242
7. Feelisch M, Noack E. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30
8. De Beider AJ, MacAllister R. Radomski MW, Moncada S, Vallance PJ. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res 1994; 28:691-694
9. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012
10. Rees D, Ben-Ishay D, Moncada S. Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 1996; 28:367-371
11. Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horizons 1993; 1:77-86
12. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
13. Liew FY. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol Lett 1994; 43:95-98
14. Vouldoukis I, Riveros-Moreno V, Dugas B et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide, induced after ligation of FCeRII/ CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92:7804-7808
15. Wei X-Q, Charles IG, Smith A. Altered immune responses in mice deficient in inducible nitric oxide synthase. Nature 1995; 375: 408-411
16. MacMicking JD, Nathan C, Hom G. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650
17. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain by nitric oxide. FEBS Lett 1994; 345:50-54
18. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996; 314:877-880
19. Moro MA, Darley-Usmar VM, Lizasoain I. The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol 1995; 116:1999-2004
20. Garthwaite J. Nitric oxide signalling in the nervous system. Neuroscience 1993; 5: 171-180
21. McMahon SB, Lewin GR, Wall PD. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993; 3:602-610
22. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 1994; 266:1713-1717
23. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW. Blockade of tolerance to morphine but not to opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993; 90:5162-5166
24. Zhang J, Snyder SH. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 1995; 35:213-233
25. Nagafuji T, Sugiyama M, Matsui T, Koide I. A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury. Eur J Pharmacol 1993; 248:325-328
26. Moskowitz MA. Effects of cerebral ischemia in mice deficient in neural nitric oxide synthase. Science 1994; 265:1883-1885.
27. Gillespie JS, Liu X, Martin W. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system. In: Moncada S, Higgs EA eds Nitric oxide from L arginine: a bioregulatory system. B.V., Amsterdam; Elsevier Science Publishers 1990: 147-164
28. Rand MJ. Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol 1992; 19: 147-169
29. Toda N. Nitric oxide and the regulation of cerebral arterial tone. In: Vincent S ed Nitric oxide in the nervous system. Academic Press Ltd 1995:207-225
30. Murad F, Ishii K, Förstermann U et al. EDRF is an intracellullar second messenger and autaoid to regulate cyclic GMP synthesis in many cells. Adv Second Messenger Phosphoprotein Res 1990;24:441-448
31. Ignarro LJ. Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism. Blood Vessels 1991;28:67-73